PMID

Title of the article

Author/s

Journal Reference

Year

12242156

Stable suppression of tumorigenicity by virus-mediated RNA interference.

Brummelkamp TR, Bernards R, Agami R

Cancer Cell. 2002 Sep;2(3):243-7

2002

11809726

Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference.

Caplen NJ, Taylor JP, Statham VS, Tanaka F, Fire A, Morgan RA.

Hum Mol Genet. 2002 Jan 15;11(2):175-84.

2002

11751575

HAT activity is essential for CBP-1-dependent transcription and differentiation in Caenorhabditis elegans.

Victor M, Bei Y, Gay F, Calvo D, Mello C, Shi Y.

EMBO Rep. 2002 Jan;3(1):50-5. Epub 2001 Dec 19.

2002

12403821

Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways.

Martinez LA, Naguibneva I, Lehrmann H, Vervisch A, Tchenio T, Lozano G, Harel-Bellan A

Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14849-54. Epub 2002 Oct 28

2002

26700961

Allele-specific silencing of mutant p53 attenuates dominant- negative and gain-of-function activities.

Martinez LA, Naguibneva I, Lehrmann H, Vervisch A, Tchenio T, Lozano G, Harel-Bellan A

Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14849-54. Epub 2002 Oct 28

2002

12782788

Allele-specific silencing of dominant disease genes.

Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL, Paulson HL.

Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7195-200. Epub 2003 Jun 2.

2003

12783425

Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA.

Gonzalez-Alegre P, Miller VM, Davidson BL, Paulson HL

Ann Neurol. 2003 Jun;53(6):781-7

2003

12928480

Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference.

Abdelgany A, Wood M, Beeson D.

Hum Mol Genet. 2003 Oct 15;12(20):2637-44. Epub 2003 Aug 19.

2003

12930974

An enhanced U6 promoter for synthesis of short hairpin RNA.

Xia XG, Zhou H, Ding H, Affar el B, Shi Y, Xu Z

Nucleic Acids Res. 2003 Sep 1;31(17):e100

2003

12934714

Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis.

Ding H, Schwarz DS, Keene A, Affar el B, Fenton L, Xia X, Shi Y, Zamore PD, Xu Z.

Aging Cell. 2003 Aug;2(4):209-17.

2003

12527766

Tolerance for mutations and chemical modifications in a siRNA.

Amarzguioui M, Holen T, Babaie E, Prydz H.

Nucleic Acids Res. 2003 Jan 15;31(2):589-95.

2003

14754988

Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles.

Miller VM, Gouvion CM, Davidson BL, Paulson HL.

Nucleic Acids Res. 2004 Jan 30;32(2):661-8. Print 2004.

2004

15236410

Sequence-dependent and independent inhibition specific for mutant ataxin-3 by small interfering RNA

Li Y, Yokota T, Matsumura R, Taira K, Mizusawa H

Ann Neurol. 2004 Jul;56(1):124-9

2004

14981234

RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells.

Maxwell MM, Pasinelli P, Kazantsev AG, Brown RH Jr

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3178-83. Epub 2004 Feb 23

2004

15241481

RNAi of COL1A1 in mesenchymal progenitor cells.

Millington-Ward S, McMahon HP, Allen D, Tuohy G, Kiang AS, Palfi A, Kenna PF, Humphries P, Farrar GJ.

Eur J Hum Genet. 2004 Oct;12(10):864-6

2004

14741366

Enhancement of RNAi activity by improved siRNA duplexes.

Hohjoh H.

FEBS Lett. 2004 Jan 16;557(1-3):193-8.

2004

16280588

Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.

Gonzalez-Alegre P, Bode N, Davidson BL, Paulson HL

J Neurosci. 2005 Nov 9;25(45):10502-9

2005

16019264

Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice.

Rodriguez-Lebron E, Denovan-Wright EM, Nash K, Lewin AS, Mandel RJ

Mol Ther. 2005 Oct;12(4):618-33

2005

16225852

Selective silencing of a mutant transthyretin allele by small interfering RNAs.

Kurosawa T, Igarashi S, Nishizawa M, Onodera O

Biochem Biophys Res Commun. 2005 Nov 25;337(3):1012-8. Epub 2005 Oct 3

2005

16113241

Tolerated wobble mutations in siRNAs decrease specificity, but can enhance activity in vivo.

Holen T, Moe SE, Sżrbż JG, Meza TJ, Ottersen OP, Klungland A.

Nucleic Acids Res. 2005 Aug 19;33(15):4704-10. Print 2005.

2005

US2005/0176045A1

SNP discriminatory siRNA

Yuriy Fedorov, Angela Reynolds, Anastasia Khvorova

US20050176045 A1

2005

US20080176812A1

Allele-specific silencing of disease genes.

Davidson Beverly L, Harper Scott, Gonzalez-Alegre Pedro,Miller Victor, Paulson Henry

US2008/0176812 A1

2005

15781493

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.

Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z.

Nucleic Acids Res. 2005 Mar 21;33(5):1671-7. Print 2005. Erratum in: Nucleic Acids Res. 2005;33(11):3698.

2005

19771217

Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles.

Ohnishi Y, Tokunaga K, Kaneko K, Hohjoh H.

J RNAi Gene Silencing. 2006 Feb 28;2(1):154-60.

2006

16857362

Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo.

Xia X, Zhou H, Huang Y, Xu Z

Neurobiol Dis. 2006 Sep;23(3):578-86. Epub 2006 Jul 20

2006

16455076

Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi.

Sapru MK, Yates JW, Hogan S, Jiang L, Halter J, Bohn MC.

Exp Neurol. 2006 Apr;198(2):382-90. Epub 2006 Feb 7.

2006

16426772

Allele-specific silencing of Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.

Feng X, Zhao P, He Y, Zuo Z.

Gene. 2006 Apr 12;371(1):68-74. Epub 2006 Jan 19.

2006

16965178

Designing siRNA that distinguish between genes that differ by a single nucleotide.

Schwarz DS, Ding H, Kennington L, Moore JT, Schelter J, Burchard J, Linsley PS, Aronin N, Xu Z, Zamore PD.

PLoS Genet. 2006 Sep 8;2(9):e140. Epub 2006 Jul 24.

2006

16520945

Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery.

Figueiredo C, Seltsam A, Blasczyk R.

J Mol Med (Berl). 2006 May;84(5):425-37. Epub 2006 Mar 7.

2006

16585504

Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism.

Dykxhoorn DM, Schlehuber LD, London IM, Lieberman J.

Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5953-8. Epub 2006 Apr 3.

2006

17145926

SiRNA-mediated selective inhibition of mutant keratin mRNAs responsible for the skin disorder pachyonychia congenita.

Hickerson RP, Smith FJ, McLean WH, Landthaler M, Leube RE, Kaspar RL.

Ann N Y Acad Sci. 2006 Oct;1082:56-61.

2006

16489337

3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.

Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y, Baskerville S, Maksimova E, Robinson K, Karpilow J, Marshall WS, Khvorova A.

Nat Methods. 2006 Mar;3(3):199-204

2006

US2007/0259827A1

Compositions And Methods For Enhancing Discriminatory Rna Interference

Neil Aronin, Dianne Schwarz, Phillip D. Zamore

US2007/0259827A1

2007

18493311

Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.

Ohnishi Y, Tamura Y, Yoshida M, Tokunaga K, Hohjoh H. PLoS One.

2008 May 21;3(5):e2248. doi: 10.1371/journal.pone.0002248.

2008

18653764

Allele-specific silencing of the dominant disease allele in sialuria by RNA interference

Klootwijk RD, Savelkoul PJ, Ciccone C, Manoli I, Caplen NJ, Krasnewich DM, Gahl WA, Huizing M

FASEB J. 2008 Nov;22(11):3846-52. doi: 10.1096/fj.08-110890. Epub 2008 Jul 24

2008

18841197

Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease.

Alves S, Nascimento-Ferreira I, Auregan G, Hassig R, Dufour N, Brouillet E, Pedroso de Lima MC, Hantraye P, Pereira de Almeida L, DŽglon N

PLoS One. 2008 Oct 8;3(10):e3341. doi: 10.1371/journal.pone.0003341

2008

19015742

Allele dependent silencing of COL1A2 using small interfering RNAs.

Lindahl K, Rubin CJ, Kindmark A, Ljunggren O.

Int J Med Sci. 2008;5(6):361-5. Epub 2008 Nov 12.

2008

18931668

Linking SNPs to CAG repeat length in Huntington's disease patients.

Liu W, Kennington LA, Rosas HD, Hersch S, Cha JH, Zamore PD, Aronin N

Nat Methods. 2008 Nov;5(11):951-3. doi: 10.1038/nmeth.1261. Epub 2008 Oct 19

2008

18776243

RNA interference in silencing of genes of Alzheimer's disease in cellular and rat brain models.

Sierant M, Kubiak K, Kazmierczak-Baranska J, Paduszynska A, Kuwabara T, Warashina M, Nacmias B, Sorbi S, Nawrot B

Nucleic Acids Symp Ser (Oxf). 2008;(52):41-2. doi: 10.1093/nass/nrn021

2008

17914454

Single-nucleotide-specific siRNA targeting in a dominant-negative skin model.

Hickerson RP, Smith FJ, Reeves RE, Contag CH, Leake D, Leachman SA, Milstone LM, McLean WH, Kaspar RL.

J Invest Dermatol. 2008 Mar;128(3):594-605. Epub 2007 Oct 11.

2008

18258738

siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.

Hewett JW, Nery FC, Niland B, Ge P, Tan P, Hadwiger P, Tannous BA, Sah DW, Breakefield XO

Hum Mol Genet. 2008 May 15;17(10):1436-45. doi: 10.1093/hmg/ddn032. Epub 2008 Feb 7

2008

18215350

Double-mismatched siRNAs enhance selective gene silencing of a mutant ALS-causing allele.

Geng CM, Ding HL.

Acta Pharmacol Sin. 2008 Feb;29(2):211-6. doi: 10.1111/j.1745-7254.2008.00740.x.

2008

18420656

Analysis of siRNA specificity on targets with double-nucleotide mismatches.

Dahlgren C, Zhang HY, Du Q, Grahn M, Norstedt G, Wahlestedt C, Liang Z.

Nucleic Acids Res. 2008 May;36(9):e53. doi: 10.1093/nar/gkn190. Epub 2008 Apr 17.

2008

17762855

Development of Therapeutic siRNAs for Pachyonychia Congenita

Smith FJ, Hickerson RP, Sayers JM, Reeves RE, Contag CH, Leake D, Kaspar RL, McLean WH

J Invest Dermatol. 2008 Jan;128(1):50-8. Epub 2007 Aug 30

2008

19289118

A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference.

Lombardi MS, Jaspers L, Spronkmans C, Gellera C, Taroni F, Di Maria E, Donato SD, Kaemmerer WF.

Exp Neurol. 2009 Jun;217(2):312-9. doi: 10.1016/j.expneurol.2009.03.004. Epub 2009 Mar 13.

2009

19532137

Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease.

Rodr’guez-Lebr—n E, Gouvion CM, Moore SA, Davidson BL, Paulson HL.

Mol Ther. 2009 Sep;17(9):1563-73. doi: 10.1038/mt.2009.123. Epub 2009 Jun 16.

2009

19094060

Allele-specific silencing of mutant Huntington's disease gene

Zhang Y, Engelman J, Friedlander RM

J Neurochem. 2009 Jan;108(1):82-90. doi: 10.1111/j.1471-4159.2008.05734.x

2009

15768029

Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.

Pfister EL, Kennington L, Straubhaar J, Wagh S, Liu W, DiFiglia M, Landwehrmeyer B, Vonsattel JP, Zamore PD, Aronin N.

Curr Biol. 2009 May 12;19(9):774-8. doi: 10.1016/j.cub.2009.03.030. Epub 2009 Apr 9.

2009

19789634

Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype.

Scholefield J, Greenberg LJ, Weinberg MS, Arbuthnot PB, Abdelgany A, Wood MJ.

PLoS One. 2009 Sep 30;4(9):e7232. doi: 10.1371/journal.pone.0007232.

2009

19165236

Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.

Mook OR, Baas F, de Wissel MB, Fluiter K.

Cancer Gene Ther. 2009 Jun;16(6):532-8. doi: 10.1038/cgt.2008.104. Epub 2009 Jan 23.

2009

US007576197B2

SiRNA targeting KRAS

Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Stephen Scaringe,Steven Read

US007576197B2

2009

19935778

First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder

Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, Hansen CD, Eliason MJ, Srivatsa GS,Kornbrust DJ, Smith FJ, McLean WI, Milstone LM, Kaspar RL

Mol Ther. 2010 Feb;18(2):442-6. doi: 10.1038/mt.2009.273. Epub 2009 Nov 24

2009

EP1567539B1

Allele-specific Rna Interference

Xu Zuoshang,Zamore Phillip D

EP1567539B1

2009

19815667

Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs.

Huang H, Qiao R, Zhao D, Zhang T, Li Y, Yi F, Lai F, Hong J, Ding X, Yang Z, Zhang L, Du Q, Liang Z.

Nucleic Acids Res. 2009 Dec;37(22):7560-9. doi: 10.1093/nar/gkp835. Epub .

2009

21095568

Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.

Hu J, Liu J, Corey DR.

Chem Biol. 2010 Nov 24;17(11):1183-8. doi: 10.1016/j.chembiol.2010.10.013.

2010

22174841

Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy.

Liao H, Irvine AD, Macewen CJ, Weed KH, Porter L, Corden LD, Gibson AB, Moore JE, Smith FJ, McLean WH, Moore CB.

PLoS One. 2011;6(12):e28582. doi: 10.1371/journal.pone.0028582. Epub 2011 Dec 12.

2011

22031823

Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson's disease.

Sibley CR, Wood MJ.

PLoS One. 2011;6(10):e26194. doi: 10.1371/journal.pone.0026194. Epub 2011 Oct 21.

2011

21559198

Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference.

Sierant M, Paduszynska A, Kazmierczak-Baranska J, Nacmias B, Sorbi S, Bagnoli S, Sochacka E, Nawrot B.

Int J Alzheimers Dis. 2011 Apr 7;2011:809218. doi: 10.4061/2011/809218.

2011

21716320

Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex.

Atkinson SD, McGilligan VE, Liao H, Szeverenyi I, Smith FJ, Moore CB, McLean WH.

J Invest Dermatol. 2011 Oct;131(10):2079-86. doi: 10.1038/jid.2011.169. Epub 2011 Jun 30.

2011

21712955

Efficient allele-specific targeting of LRRK2 R1441 mutations mediated by RNAi.

de Y–igo-Mojado L, Mart’n-Ru’z I, Sutherland JD.

PLoS One. 2011;6(6):e21352. doi: 10.1371/journal.pone.0021352. Epub 2011 Jun 21.

2011

21364589

Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin

Rachagani S, Senapati S, Chakraborty S, Ponnusamy MP, Kumar S, Smith LM, Jain M, Batra SK

Br J Cancer. 2011 Mar 15;104(6):1038-48. doi: 10.1038/bjc.2011.31. Epub 2011 Mar 1

2011

21427085

Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats.

Fiszer A, Mykowska A, Krzyzosiak WJ.

Nucleic Acids Res. 2011 Jul;39(13):5578-85. doi: 10.1093/nar/gkr156. Epub 2011 Mar 22.

2011

21294677

Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs

Hu J, Gagnon KT, Liu J, Watts JK, Syeda-Nawaz J, Bennett CF, Swayze EE, Randolph J, Chattopadhyaya J, Corey DR

Biol Chem. 2011 Apr;392(4):315-25. doi: 10.1515/BC.2011.045. Epub 2011 Feb 7

2011

23152933

Allele-specific gene silencing in two mouse models of autosomal dominant skeletal myopathy.

Loy RE, Lueck JD, Mostajo-Radji MA, Carrell EM, Dirksen RT.

PLoS One. 2012;7(11):e49757. doi: 10.1371/journal.pone.0049757. Epub 2012 Nov 12.

2012

22336946

siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.

Pendaries V, Gasc G, Titeux M, Tonasso L, Mej’a JE, Hovnanian A.

J Invest Dermatol. 2012 Jun;132(6):1741-3. doi: 10.1038/jid.2012.11. Epub 2012 Feb 16.

2012

22038052

Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts.

Mźller GA, Hansen U, Xu Z, Griswold B, Talan MI, McDonnell NB, Briest W.

FASEB J. 2012 Feb;26(2):668-77. doi: 10.1096/fj.11-182162. Epub 2011 Oct 28.

2012

22130450

Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva.

Takahashi M, Katagiri T, Furuya H, Hohjoh H.

Gene Ther. 2012 Jul;19(7):781-5. doi: 10.1038/gt.2011.193. Epub 2011 Dec 1.

2012

22402445

Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder.

Leslie Pedrioli DM, Fu DJ, Gonzalez-Gonzalez E, Contag CH, Kaspar RL, Smith FJ, McLean WH.

J Invest Dermatol. 2012 Jun;132(6):1627-35. doi: 10.1038/jid.2012.28. Epub 2012 Mar 8.

2012

23042244

Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway.

Hu J, Liu J, Yu D, Chu Y, Corey DR.

Nucleic Acids Res. 2012 Dec;40(22):11270-80. doi: 10.1093/nar/gks907. Epub 2012 Oct 4.

2012

22939619

Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression.

Yu D, Pendergraff H, Liu J, Kordasiewicz HB, Cleveland DW, Swayze EE, Lima WF, Crooke ST, Prakash TP, Corey DR.

Cell. 2012 Aug 31;150(5):895-908. doi: 10.1016/j.cell.2012.08.002.

2012

22397573

An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.

Fiszer A, Olejniczak M, Switonski PM, Wroblewska JP, Wisniewska-Kruk J, Mykowska A, Krzyzosiak WJ.

BMC Mol Biol. 2012 Mar 7;13:6. doi: 10.1186/1471-2199-13-6.

2012

23349684

Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice

N—brega C, Nascimento-Ferreira I, Onofre I, Albuquerque D, Hirai H, DŽglon N, de Almeida LP

PLoS One. 2013;8(1):e52396. doi: 10.1371/journal.pone.0052396. Epub 2013 Jan 22

2013

23233254

Allele-specific siRNA silencing for the common keratin 12 founder mutation in Meesmann epithelial corneal dystrophy.

Allen EH, Atkinson SD, Liao H, Moore JE, Leslie Pedrioli DM, Smith FJ, McLean WH, Moore CB.

Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):494-502. doi: 10.1167/iovs.12-10528.

2013

24092743

Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy.

Jiang J, Wakimoto H, Seidman JG, Seidman CE.

Science. 2013 Oct 4;342(6154):111-4. doi: 10.1126/science.1236921.

2013

23951344

Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference.

Takahashi M, Chiyo T, Okada T, Hohjoh H.

PLoS One. 2013 Aug 8;8(8):e73214. doi: 10.1371/journal.pone.0073214. eCollection 2013.

2013

23470493

Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes

Matsa E, Dixon JE, Medway C, Georgiou O, Patel MJ, Morgan K, Kemp PJ, Staniforth A, Mellor I, Denning C

Eur Heart J. 2014 Apr;35(16):1078-87. doi: 10.1093/eurheartj/eht067. Epub 2013 Mar 6

2014

24022296

Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta.

Rousseau J, Gioia R, Layrolle P, Lieubeau B, Heymann D, Rossi A, Marini JC, Trichet V, Forlino A.

Eur J Hum Genet. 2014 May;22(5):667-74. doi: 10.1038/ejhg.2013.198. Epub 2013 Sep 11.

2014

24355919

Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice

Guo S, Booten SL, Aghajan M, Hung G, Zhao C, Blomenkamp K, Gattis D, Watt A, Freier SM, Teckman JH, McCaleb ML, Monia BP

J Clin Invest. 2014 Jan;124(1):251-61. doi: 10.1172/JCI67968. Epub 2013 Dec 20

2014

24518369

siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy.

Bolduc V, Zou Y, Ko D, Bšnnemann CG.

Mol Ther Nucleic Acids. 2014 Feb 11;3:e147. doi: 10.1038/mtna.2013.74.

2014

24694346

Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs.

Hu J, Liu J, Yu D, Aiba Y, Lee S, Pendergraff H, Boubaker J, Artates JW, Lagier-Tourenne C, Lima WF, Swayze EE, Prakash TP, Corey DR.

Nucleic Acid Ther. 2014 Jun;24(3):199-209. doi: 10.1089/nat.2013.0476. Epub 2014 Apr 2

2014

24801514

siRNA silencing of the mutant keratin 12 allele in corneal limbal epithelial cells grown from patients with Meesmann's epithelial corneal dystrophy

Courtney DG, Atkinson SD, Allen EH, Moore JE, Walsh CP, Pedrioli DM, MacEwen CJ, Pellegrini G, Maurizi E, Serafini C, Fantacci M, Liao H, Irvine AD, McLean WH, Moore CB.

Invest Ophthalmol Vis Sci. 2014 May 6;55(5):3352-60. doi: 10.1167/iovs.13-12957

2014

24926995

Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells.

Drouet V, Ruiz M, Zala D, Feyeux M, Auregan G, Cambon K, Troquier L, Carpentier J, Aubert S, Merienne N, Bourgois-Rocha F, Hassig R, Rey M, Dufour N, Saudou F, Perrier AL, Hantraye P, DŽglon N.

PLoS One. 2014 Jun 13;9(6):e99341. doi: 10.1371/journal.pone.0099341. eCollection 2014

2014

24959844

Allele-specific Gene Silencing of Mutant mRNA Restores Cellular Function in Ullrich Congenital Muscular Dystrophy Fibroblasts.

Noguchi S, Ogawa M, Kawahara G, Malicdan MC, Nishino I.

Mol Ther Nucleic Acids. 2014 Jun 24;3:e171. doi: 10.1038/mtna.2014.22

2014

24981774

Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs.

Hu J, Liu J, Narayanannair KJ, Lackey JG, Kuchimanchi S, Rajeev KG, Manoharan M, Swayze EE, Lima WF, Prakash TP, Xiang Q, Martinez C, Corey DR

Biochemistry. 2014 Jul 22;53(28):4510-8. doi: 10.1021/bi500610r. Epub 2014 Jul 11

2014

24425855

Development of allele-specific gene-silencing siRNAs for TGFBI Arg124Cys in lattice corneal dystrophy type I

Courtney DG, Atkinson SD, Moore JE, Maurizi E, Serafini C, Pellegrini G, Black GC, Manson FD, Yam GH, Macewen CJ, Allen EH, McLean WH, Moore CB

Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):977-85. doi: 10.1167/iovs.13-13279

2014

US8859752B2

Sirna-based Therapy Of Fibrodyplasia Ossificans Progressiva (fop)

Kaplan Frederick S, Shore Eileen M

US8859752B2

2014

25965551

Normalization of Overexpressed α-Synuclein Causing ParkinsonŐs Disease By a Moderate Gene Silencing With RNA Interference

Takahashi M, Suzuki M, Fukuoka M, Fujikake N, Watanabe S, Murata M, Wada K, Nagai Y, Hohjoh H

Mol Ther Nucleic Acids. 2015 May 12;4:e241. doi: 10.1038/mtna.2015.14

2015

25849618

Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo

Monteys AM,Wilson MJ,Boudreau RL,Spengler RM,Davidson BL

Mol Ther Nucleic Acids. 2015 Apr 7;4:e234. doi: 10.1038/mtna.2015.7

2015

25586224

Efficient CRISPR-rAAV engineering of endogenous genes to study protein function by allele-specific RNAi

Kaulich M, Lee YJ, Lšnn P, Springer AD, Meade BR, Dowdy SF

Nucleic Acids Res. 2015 Apr 20;43(7):e45. doi: 10.1093/nar/gku1403. Epub 2015 Jan 13

2015

27195674

Allele-specific silencing of EEC p63 mutant R304W restores p63 transcriptional activity

Novelli F, Lena AM, Panatta E, Nasser W, Shalom-Feuerstein R, Candi E, Melino G.

Cell Death Dis. 2016 May 19;7:e2227. doi: 10.1038/cddis.2016.118

2016

26891374

Correction of mutant p63 in EEC syndrome using siRNA mediated allele specific silencing restores defective stem cell function

Barbaro V, Nasti AA, Del Vecchio C, Ferrari S, Migliorati A, Raffa P, Lariccia V, Nespeca P, Biasolo M, Willoughby CE4, Ponzin D, Palť G, Parolin C, Di Iorio E,.

Stem Cells. 2016 Feb 17. doi: 10.1002/stem.2343

2016

26763422

Correction of Hair Shaft Defects through Allele-Specific Silencing of Mutant Krt75

Liu Y, Snedecor ER, Zhang X, Xu Y, Huang L, Jones EC, Zhang L, Clark RA, Roop DR, Qin C, Chen J

J Invest Dermatol. 2016 Jan;136(1):45-51. doi: 10.1038/JID.2015.375

2016

27003758

A Small Indel Mutant Mouse Model of Epidermolytic Palmoplantar Keratoderma and Its Application to Mutant-specific shRNA Therapy

Ya-Su Lyu, Pei-liang Shi, Xiao-Ling Chen, Yue-Xiao Tang, Yan-Fang Wang, Rong-Rong Liu, Xiao-Rui Luan, Yu Fang4, Ru-Huan Mei4 Zhen-Fang Du, Hai-Ping Ke5, Erik Matro6, Ling-En Li, Zhao-Yu Lin, Jing Zhao, Xiang Gao and Xian-Ning Zhang

Mol Ther Nucleic Acids. 2016 Mar 22;5:e299. doi: 10.1038/mtna.2016.17

2016

27003755

Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease

Miniarikova J,, Zanella I, Huseinovic A, van der Zon T, Hanemaaijer E, Martier R,, Koornneef A, Southwell AL, Hayden MR, van Deventer SJ, Petry H, Konstantinova P.

Mol Ther Nucleic Acids. 2016 Mar 22;5:e297. doi: 10.1038/mtna.2016.7.

2016